Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Evidence has been arising that Botulinum toxin injections can relax smooth muscles fibers in
the treatment of obesity and hyperactive bladder. Would a similar effect on cavernosal smooth
muscles help in the treatment of resistant erectile dysfunction not responding to medical and
injection therapy, thus avoiding surgical treatment options.
The treatment group will be injected intracavernously with 50 units of BTX-A. The control
group, 12 patients, will be injected with a normal saline injection.
Phase:
Phase 1
Details
Lead Sponsor:
Cairo University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA Pharmaceutical Solutions